Ironwood’s Phase III Data Could Expand Linzess Market Share

 
• By Alaric DeArment
  
Phase III pediatric data could expand market share for Ironwood's Linzess • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Therapeutic Category